Comparing the Efficacy of Intra-Lesional Injection versus Systemic Steroids in Treating Idiopathic Granulomatous Mastitis
Abstract
Objective: To compare the clinical efficacy, safety and patients satisfaction of intra-lesional steroid injections versus systemic steroid therapy in the management of idiopathic granulomatous mastitis (IGM) among female patients presenting to a tertiary care Hospital.
Methods: This prospective comparative cohort study was carried out at general surgery department of LUMHS, from July 2025 to December 2025. Women patients aged >8 years, presented with suggestive of idiopathic granulomatous mastitis without prior corticosteroid treatment in the past 3 months were included. Patients were allocated to the intralesional corticosteroid injection group or the systemic corticosteroid group according to clinical decisions and preference of the patients. The cases of Group A received corticosteroid injections directly into the granulomatous lesions using a 22–23G needle under aseptic technique, under ultrasound guidance and cases of Group B received systemic corticosteroid treatment. Patients were followed up every two weeks during treatment and then at 1 and 3 months after completion the treatment. All the relevant data were entered and analyzed using SPSS version 26.
Results: Mean age of the intralesional steroid group patients was 33.57 ± 7.25 years and systemic steroid group was 37.85 ± 6.58 years without significant difference (p = 0.114). Cases who were treated with intralesional steroids improved clinically significantly earlier (3.28 ± 1.48 vs 5.57 ± 2.13 weeks), (p = 0.003) and achieved quick complete resolution (7.57 ± 2.10 vs 10.57 ± 2.65 weeks), p = 0.002. Complete resolution rates were higher in intralesional steroids group (92.9% vs 78.6%) while statistically insignificant (p = 0.280), and no recurrence occurred in either group. Adverse effects were mild and local with intralesional injection, whereas the systemic group mainly experienced weight gain with bloating or anxiety (p = 0.031). Overall satisfaction was 85.7% with intralesional steroids and 57.1% with systemic steroids (p = 0.336).
Conclusion: Both treatment approaches achieved the comparable resolution rates, while ILS injection can be considered a safe first-line alternative to systemic steroids in treating idiopathic granulomatous mastitis, with early improvement and resolution and very limited in ejection site related local side effects.
Metrics
Keywords
License
Copyright (c) 2026 Rahmat Urf Sehrish Shah, Shakila Jhatial, Ambreen Munir, Anita Kumari, Qurat ul Ain, Mujeeb-Ur- Rehman

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.